tradingkey.logo
tradingkey.logo
Search

SI-BONE Inc

SIBN
Add to Watchlist
17.110USD
+0.310+1.85%
Close 07/02, 13:00ETQuotes delayed by 15 min
756.29MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+1.85%

5 Days

+2.09%

1 Month

+22.13%

6 Months

-13.54%

Year to Date

-13.24%

1 Year

-7.16%

Key Figures
16.910Open
17.140High
473.92KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.07%Turnover Ratio
16.800Prev. Close
16.450Low
5.37MTurnover
LossP/E Static
4.23P/B
0.00%Div Yield TTM
-7.10%ROA
21.89052wk High
0.88Volume Ratio
-30.91MNet Profit
44.20MShares
-0.3841EPS TTM
0.70Beta
-9.65%ROE
11.48052wk Low
4.11%Amplitude
79.76%Gross Margin
756.29MMarket Cap
7.66Reward/Risk
2.70%Risk Rate

TradingKey Stock Score of SI-BONE Inc

Currency: USD Updated: 2026-07-02

Key Insights

SI-BONE Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SI-BONE Inc's Score

Industry at a Glance

Industry Ranking
28 / 204
Overall Ranking
88 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

SI-BONE Inc Highlights

StrengthsRisks
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.67% year-on-year.
Undervalued
The company’s latest PE is -44.54, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.75M shares, decreasing 4.78% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 215.77K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.19.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
24.000
Target Price
+42.18%
Upside Space

SI-BONE Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

SI-BONE Inc Info

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Ticker SymbolSIBN
CompanySI-BONE Inc
CEOFrancis (Laura A)
Websitehttps://si-bone.com/

FAQs

What is the current price of SI-BONE Inc (SIBN)?

The current price of SI-BONE Inc (SIBN) is 17.11.

What is the symbol of SI-BONE Inc?

The ticker symbol of SI-BONE Inc is SIBN.

What is the 52-week high of SI-BONE Inc?

The 52-week high of SI-BONE Inc is 21.89.

What is the 52-week low of SI-BONE Inc?

The 52-week low of SI-BONE Inc is 11.48.

What is the market capitalization of SI-BONE Inc?

The market capitalization of SI-BONE Inc is 756.29M.

Is SI-BONE Inc (SIBN) currently rated as Buy, Hold, or Sell?

According to analysts, SI-BONE Inc (SIBN) has an overall rating of Buy, with a price target of 24.00.

What is the Earnings Per Share (EPS TTM) of SI-BONE Inc (SIBN)?

The Earnings Per Share (EPS TTM) of SI-BONE Inc (SIBN) is -0.44.